According to a recently published study, the effectiveness of the H3N2 vaccine could be attributed to the egg-based vaccine production process, which may ultimately render the vaccine to be less effective in humans.
Browsing: Clinical > Vaccines
Researchers have uncovered five new targets for malaria vaccine development, suggesting that targeting multiple steps of erythrocyte invasion is more likely to produce an effective vaccine.
In line with our focus this month on all aspects of influenza, we spoke to Ed Schmidt, project manager of the Universal Influenza Vaccines Secured (UNISEC) consortium, about its aim to develop a universal flu vaccine.
Researchers have reported an acceptable safety and immunogenicity profile of an Ebola vaccine in adults and potentially in children in Africa – indicating that the vaccine produces an immune response and is considered safe.
A new DNA-based Zika vaccine, GLS-5700, has been reported as safe and immunogenic in Phase I trial, according to new research.
Researchers have demonstrated the having a positive mood on the day of flu vaccination may predict and even improve vaccine effectiveness.
Read our report covering the Knowledge Transfer Network’s vaccine development and manufacture event, focusing on the future innovation landscape for the UK and covering topics from new technologies to scale-down models for producing cheaper vaccines.
In this report we look at the burden of cryptococcal meningitis, issues with current treatment regimens and future research directions.